OBIO Orchestra BioMed Holdings, Inc.
Nasdaq · SEC CIK 1814114 · EDGAR
- Bought, last 12 months
- $279.9K 9 purchases by 4 insiders
- Sold, last 12 months
- $257.7K 5 sales by 2 insiders
- Filings on record
- 173 since 2022-07-25, latest 2026-09-11 18:11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Sherman Darren | See Remarks, Dir | $10.7K | $257.6K |
| Hochman David P | See Remarks, Dir | $149.2K | — |
| Fain Eric S | Dir | $82.6K | — |
| Aryeh Jason | Dir | $37.5K | — |
| RTW INVESTMENTS, LP | 10% | — | $132.16 |
| Cleary Chris | Dir | — | — |
| Mack John Prosper | Dir | — | — |
| Aiello Joshua | Principal Accounting Off | — | — |
| Connealy Pamela Ann | Dir | — | — |
| Taylor Andrew Lawrence | CFO | — | — |
Transactions 168
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | 2024-12-19 | OBIO | Taylor Andrew Lawrence | CFO | P - Purchase | $4.83 | +1,000 | 345.0K | +0.3% | +$4,830 | |
| 2024-12-19 | 2024-12-18 | OBIO | Hochman David P | See Remarks, Dir | P - Purchase | $4.91 | +5,000 | 575.5K | +0.9% | +$24.6K | |
| 2024-12-13 | 2024-12-12 | OBIO | Taylor Andrew Lawrence | CFO | F - Tax | $5.03 | -34.4K | 344.0K | -9% | -$173.0K | |
| 2024-12-06 | 2024-12-05 | OBIO | Sherman Darren | See Remarks, Dir | F - Tax | $5.57 | -31.8K | 734.0K | -4% | -$177.2K | |
| 2024-09-26 | 2024-09-24 | OBIO | Hochman David P | See Remarks, Dir | P - Purchase | $4.91 | +2,500 | 570.5K | +0.4% | +$12.3K | |
| MI | 2024-09-26 | 2024-09-25 | OBIO | Hochman David P | See Remarks, Dir | P - Purchase | $4.75 | +7,500 | 335.0K | +2% | +$35.6K |
| MI | 2024-09-10 | 2024-09-06+ | OBIO | Fain Eric S | Dir | S - Sale | $5.48 | -5,600 | 43.0K | -12% | -$30.7K |
| M | 2024-09-10 | 2024-09-09+ | OBIO | Sherman Darren | See Remarks, Dir | S - Sale | $5.39 | -13.7K | 772.7K | -2% | -$73.9K |
| M | 2024-09-06 | 2024-09-04+ | OBIO | Sherman Darren | See Remarks, Dir | S - Sale | $5.87 | -20.6K | 793.3K | -3% | -$121.0K |
| 2024-08-15 | 2024-08-14 | OBIO | Hochman David P | See Remarks, Dir | P - Purchase | $5.84 | +2,500 | 568.0K | +0.4% | +$14.6K | |
| D | 2024-08-08 | 2024-08-07 | OBIO | Mack John Prosper | Dir | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
| 2024-08-07 | 2024-08-05 | OBIO | HSAC 2 Holdings, LLC | 10% | J - Other | $0.00 | -3.41M | 1.71M | -67% | $0 | |
| I | 2024-06-26 | 2024-06-25 | OBIO | Hochman David P | See Remarks, Dir | P - Purchase | $6.95 | +1,000 | 333.5K | +0.3% | +$6,950 |
| D | 2024-06-21 | 2024-06-20 | OBIO | Aryeh Jason | Dir | A - Grant | $0.00 | +5,376 | 68.4K | +9% | $0 |
| DI | 2024-06-21 | 2024-06-20 | OBIO | Fain Eric S | Dir | A - Grant | $0.00 | +5,376 | 46.8K | +13% | $0 |
| D | 2024-06-21 | 2024-06-20 | OBIO | Pacitti David | Dir | A - Grant | $0.00 | +5,376 | 17.5K | +44% | $0 |
| D | 2024-06-21 | 2024-06-20 | OBIO | ROSE ERIC A MD | Dir | A - Grant | $0.00 | +5,376 | 7,544 | +248% | $0 |
| D | 2024-06-21 | 2024-06-20 | OBIO | Connealy Pamela Ann | Dir | A - Grant | $0.00 | +5,376 | 21.3K | +34% | $0 |
| 2024-06-03 | 2024-05-30 | OBIO | Little William Reed | See Remarks | P - Purchase | $7.00 | +4,000 | 307.9K | +1% | +$28.0K | |
| MAI | 2024-05-21 | 2024-05-16+ | OBIO | Hochman David P | See Remarks, Dir | P - Purchase | $4.99 | +5,000 | 329.5K | +2% | +$24.9K |
| MI | 2024-05-20 | 2024-05-16+ | OBIO | Hochman David P | See Remarks, Dir | A - Grant | $4.99 | +5,000 | 332.5K | +2% | +$24.9K |
| 2024-05-10 | 2024-05-08 | OBIO | Little William Reed | See Remarks | A - Grant | $0.00 | +53.3K | 303.9K | +21% | $0 | |
| 2024-05-10 | 2024-05-08 | OBIO | Mika Yuval | See Remarks | A - Grant | $0.00 | +69.3K | 158.9K | +77% | $0 | |
| D | 2024-05-10 | 2024-05-08 | OBIO | Papandreou George | See Remarks | A - Grant | $0.00 | +22.0K | 42.0K | +110% | $0 |
| 2024-05-10 | 2024-05-08 | OBIO | Taylor Andrew Lawrence | CFO | A - Grant | $0.00 | +100.0K | 378.4K | +36% | $0 | |
| I | 2024-05-10 | 2024-05-08 | OBIO | Hochman David P | See Remarks, Dir | A - Grant | $0.00 | +100.0K | 327.5K | +44% | $0 |
| 2024-05-10 | 2024-05-08 | OBIO | Hochman David P | See Remarks, Dir | A - Grant | $0.00 | +100.0K | 565.5K | +21% | $0 | |
| 2024-05-10 | 2024-05-08 | OBIO | Sherman Darren | See Remarks, Dir | A - Grant | $0.00 | +176.7K | 800.1K | +28% | $0 | |
| D | 2024-03-28 | 2024-03-26 | OBIO | Pacitti David | Dir | A - Grant | $0.00 | +10.0K | 12.2K | +461% | $0 |
| 2023-07-24 | 2023-07-20 | OBIO | Smith Geoffrey Wade | Dir | A - Grant | $0.00 | +16.7K | 20.9K | +393% | $0 | |
| 2023-07-24 | 2023-07-20 | OBIO | Mika Yuval | See Remarks | A - Grant | $0.00 | +40.0K | 89.6K | +81% | $0 | |
| D | 2023-07-24 | 2023-07-20 | OBIO | Aiello Joshua | Principal Accounting Off | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 |
| 2023-07-24 | 2023-07-20 | OBIO | Little William Reed | See Remarks | A - Grant | $0.00 | +250.5K | 250.5K | New | $0 | |
| DI | 2023-07-24 | 2023-07-20 | OBIO | Fain Eric S | Dir | A - Grant | $0.00 | +11.7K | 41.4K | +39% | $0 |
| DI | 2023-07-24 | 2023-07-20 | OBIO | Hochman David P | See Remarks, Dir | A - Grant | $0.00 | +165.0K | 227.5K | +264% | $0 |
| D | 2023-07-24 | 2023-07-20 | OBIO | Hochman David P | See Remarks, Dir | A - Grant | $0.00 | +300.0K | 465.5K | +181% | $0 |
| D | 2023-07-24 | 2023-07-20 | OBIO | Connealy Pamela Ann | Dir | A - Grant | $0.00 | +11.7K | 15.9K | +275% | $0 |
| 2023-07-24 | 2023-07-20 | OBIO | Sherman Darren | See Remarks, Dir | A - Grant | $0.00 | +539.7K | 623.4K | +644% | $0 | |
| 2023-07-24 | 2023-07-20 | OBIO | Taylor Andrew Lawrence | CFO | A - Grant | $0.00 | +278.4K | 278.4K | New | $0 | |
| D | 2023-05-19 | 2023-05-17 | OBIO | ROSE ERIC A MD | Dir | F - Tax | $16.04 | -157 | 2,168 | -7% | -$2,518 |
| D | 2023-05-19 | 2023-05-17 | OBIO | ROSE ERIC A MD | Dir | M - OptEx | $1.08 | +2,325 | 2,325 | New | +$2,511 |
| DI | 2023-05-12 | 2023-05-10 | OBIO | Fain Eric S | Dir | M - OptEx | $1.08 | +2,906 | 29.8K | +11% | +$3,138 |
| DMI | 2023-05-08 | 2023-04-12 | OBIO | Smith Geoffrey Wade | Dir | M - OptEx | — | +327.6K | 245.1K | New | — |
| D | 2023-05-08 | 2023-04-12 | OBIO | Smith Geoffrey Wade | Dir | M - OptEx | — | +758 | 4,246 | +22% | — |
| D | 2023-05-05 | 2023-04-12 | OBIO | Sherman Darren | See Remarks, Dir | M - OptEx | — | +15.0K | 83.8K | +22% | — |
| I | 2023-05-05 | 2023-04-13 | OBIO | RTW INVESTMENTS, LP | 10% | J - Other | — | +502.1K | 5.62M | +10% | — |
| D | 2023-05-05 | 2023-04-12 | OBIO | Aryeh Jason | Dir | M - OptEx | — | +11.2K | 63.0K | +22% | — |
| D | 2023-05-05 | 2023-04-12 | OBIO | Kaswan Michael | CFO | M - OptEx | — | +29.0K | 162.6K | +22% | — |
| D | 2023-05-05 | 2023-04-12 | OBIO | Yanchik Connealy Pamela | Dir | M - OptEx | — | +758 | 4,246 | +22% | — |
| D | 2023-05-05 | 2023-04-12 | OBIO | Mika Yuval | See Remarks | M - OptEx | — | +8,852 | 49.6K | +22% | — |
| DA | 2023-05-05 | 2023-01-26 | OBIO | Sherman Darren | See Remarks, Dir | A - Grant | — | +68.8K | 68.8K | New | — |
| D | 2023-05-05 | 2023-04-12 | OBIO | Hochman David P | See Remarks, Dir | M - OptEx | — | +29.6K | 165.5K | +22% | — |
| DMI | 2023-05-05 | 2023-04-12 | OBIO | Hochman David P | See Remarks, Dir | M - OptEx | — | +11.8K | 62.5K | +23% | — |
| DI | 2023-05-05 | 2023-04-12 | OBIO | Fain Eric S | Dir | M - OptEx | — | +4,796 | 26.9K | +22% | — |
| I | 2023-02-01 | 2023-01-30 | OBIO | Medtronic plc | 10% | P - Purchase | $9.28 | +6,835 | 5.00M | +0.1% | +$63.4K |
| D | 2023-01-30 | 2023-01-26 | OBIO | Aryeh Jason | Dir | A - Grant | — | +51.7K | 51.7K | New | — |
| I | 2023-01-30 | 2023-01-26 | OBIO | RTW INVESTMENTS, LP | 10% | A - Grant | — | +2.31M | 5.12M | +82% | — |
| D | 2023-01-30 | 2023-01-26 | OBIO | Mika Yuval | See Remarks, Dir | A - Grant | — | +40.7K | 40.7K | New | — |
| D | 2023-01-30 | 2023-01-26 | OBIO | Smith Geoffrey Wade | Dir | A - Grant | — | +3,488 | 3,488 | New | — |
| DMI | 2023-01-30 | 2023-01-26 | OBIO | Smith Geoffrey Wade | Dir | A - Grant | — | +1.51M | 201.3K | New | — |
| DI | 2023-01-30 | 2023-01-26 | OBIO | Fain Eric S | Dir | A - Grant | — | +22.1K | 22.1K | New | — |
| D | 2023-01-30 | 2023-01-26 | OBIO | Kaswan Michael | CFO | A - Grant | — | +133.5K | 133.5K | New | — |
| D | 2023-01-30 | 2023-01-26 | OBIO | Sherman Darren | See Remarks, Dir | A - Grant | — | +68.2K | 68.2K | New | — |
| D | 2023-01-30 | 2023-01-26 | OBIO | Yanchik Connealy Pamela | Dir | A - Grant | — | +3,488 | 3,488 | New | — |
| DMI | 2023-01-30 | 2023-01-26 | OBIO | Hochman David P | See Remarks, Dir | A - Grant | — | +54.5K | 51.3K | New | — |
| D | 2023-01-30 | 2023-01-26 | OBIO | Hochman David P | See Remarks, Dir | A - Grant | — | +135.9K | 135.9K | New | — |
| I | 2023-01-26 | 2023-01-24 | OBIO | WONG RODERICK | CEO, Dir, 10% | P - Purchase | $10.00 | +1.81M | 2.81M | +181% | +$18.09M |
| I | 2022-07-25 | 2022-07-22 | OBIO | WONG RODERICK | CEO, Dir | P - Purchase | $10.01 | +1.00M | 1.00M | New | +$10.01M |
Purchase Sale Sale after option exercise All abbreviations